Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Int J Eat Disord. 2022 Dec 1;56(2):384–393. doi: 10.1002/eat.23867

Table 3a.

Linear Regressions in non-FBT treatment modalities for AN

Predictors Cont. DV F R2
Change
p B 95%CI
Income EBW EOT 3.26 .000 .89 −.001 −.02-.02
EDE EOT 27.96 .005 .37 −.001 −.003-.001
Illness duration EBW EOT 4.86 .02 .10 −.10 −.22-.01
EDE EOT 27.67 .002 .61 .004 −.01-.02
PVAN scores BL EBW EOT 4.49 .01 .28 −.33 −.92-.27
EDE EOT 5.48 .001 .78 −.01 −.10-.07
Comorbidity (yes/no) EBW EOT 4.02 .000 .81 .40 −2.97-3.77
EDE EOT 30.20 .01 .12 .39 −.10-.87
Intact Family EBW EOT 4.04 .001 .77 .53 −3.10-4.15
EDE EOT 30.19 .01 .12 .38 −.10-.84
Prior Treatment EBW EOT 4.63 .01 .17 2.47 −1.05-5.99
EDE EOT 27.56 .000 .80 −.07 −.58-.45
Prior Hospitalization EBW EOT 3.64 .000 .82 .40 −2.90-3.60
EDE EOT 28.42 .007 .27 −.24 −.67-.19
Sex EBW EOT 3.96 .004 .45 .06 −3.5-7.89
EDE EOT 19.25 .007 .30 −.08 −1.26-.39

Note: EDE: Eating Disorders Examination, EOT: End of Treatment, EBW: Expected Body Weight, FBT: Family based treatment